site stats

Gensight market cap

WebIndustries Industries Technology Axiata’s Tower Arm Shortlists Bidders for $750 Million Stake Sale Markets Postal Bank Gains After China Mobile Buys $6.5 Billion Stake Featured Business of Sports... WebMarket Cap $177.41 M Shares Outstanding 46.34 M Public Float 31.92 M Yield GSGTF is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short …

GenSight Biologics ENXTPA:SIGHT Stock Report - Simply Wall St

WebGet the latest Gensight Biologics SA (SIGHT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebFeb 27, 2024 · Market Capitalization €145.9 M 2024-02-27 Revenue €5.3 M FY, 2024 Company summary Overview GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. the gifts and ministry of the holy spirit https://accweb.net

Investors & media – GenSight Biologics

WebGENSIGHT BIOLOGICS SA Daily – Vickers Top Insider Picks for 12/31/2024 The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with... WebFeb 2, 2024 · Public company founded in 2012 dedicated to developing and commercializing gene therapies for neurodegenerative retinal diseases and diseases of the central … WebStock analysis for GenSight Biologics SA (SIGHT:EN Paris) including stock price, stock chart, company news, key statistics, fundamentals and company profile. the ark syfy plot

GenSight Biologics S.A. (GSGTF) - Yahoo Finance

Category:GenSight Biologics S.A. (GSGTF) Stock Price Today, Quote …

Tags:Gensight market cap

Gensight market cap

GenSight Biologics S.A. (GSGTF) Stock Price, Quote, News …

WebMar 29, 2024 · Market Cap €97.6M; Shares Outstanding 46.34M; Public Float 31.92M; Beta N/A; Rev. per Employee €68.42K; P/E Ratio N/A; EPS N/A; Yield N/A; Dividend N/A; Ex … WebView the latest GenSight Biologics S.A. (SIGHT) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Gensight market cap

Did you know?

WebApr 3, 2024 · GenSight Biologics - GSGTF Competitors $3.10 0.00 (0.00%) (As of 04/3/2024 12:00 AM ET) Compare Today's Range $3.10 $3.10 50-Day Range $3.10 $3.10 52-Week Range $3.10 $3.50 Volume 25 shs Average Volume 767 shs Market Capitalization N/A P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile Analyst … WebSearch stock, chart, recent trades, company information, trading information, company news, fundamentals

WebThe average market cap of companies in the sector is 192.3 M with a standard deviation of 297.2 M. GenSight Biologics S.A.'s Market Cap of 178.9 M ranks in the 70.9% percentile … WebGenSight Biologics Market Capitalization is currently at 171.79 M. Market Capitalization is the total market value of GenSight Biologics' equity. It is one of many ways to value …

WebSep 2, 2024 · GenSight at the forefront of Gene Therapy in ophthalmology Publicly traded Biotech company Seasoned management team with strong BioPharma and Financial markets experience Differentiated gene therapy approach forming a technology platform leveraging disruptive gene therapies in ophthalmology and broader WebReal-time Data is provided using Nasdaq Last Sale Data Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their …

WebApr 3, 2024 · A high-level overview of GenSight Biologics S.A. (GSGTF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …

WebDefinition of GAINSIGHT in the Definitions.net dictionary. Meaning of GAINSIGHT. What does GAINSIGHT mean? Information and translations of GAINSIGHT in the most … the gifts and callings without repentance kjvWebDec 31, 2024 · 44. Free-Float. 87,2%. More Financials. Company. GenSight Biologics S.A. specializes in the research and development of gene therapies for the treatment of … the gifts and calling of god kjvWebJan 1, 2024 · GenSight Biologics SA Market Capitalization: Historic Market Cap and Yearly Evolution Market Cap GenSight Biologics SA Market Capitalization: €173.2 … the gifts and calling are without repentanceWebMarket Cap: 112.174M: Beta (5Y Monthly) 2.21: PE Ratio (TTM) N/A: EPS (TTM)-0.6500: Earnings Date: Mar 24, 2024: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Est: 9.40 Find out all the key statistics for GenSight Biologics S.A. (SIGHT.PA), including … Stocks sink after Fed minutes despite cooler inflation: Stock market news … PARIS, March 10, 2024--Regulatory News: GenSight Biologics (Euronext: SIGHT, … Find the latest GenSight Biologics S.A. (SIGHT.PA) stock discussion in Yahoo … the gift scholars limitedWebApr 7, 2024 · SIGHT’s market cap is 106.17 Mil. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often … the gift scholars ltdWebGensight Biologics Market Capitalization is currently at 165.35 M. Market Capitalization is the total market value of Gensight Biologics' equity. It is one of many ways to value … the ark syfy reviewsWebFeb 5, 2024 · GenSight Biologics (ENXTPA:SIGHT) - Stock Price, News & Analysis - Simply Wall St Stocks / France / Pharmaceuticals & Biotech GenSight Biologics … the gifts and ministries of the holy spirit